Somatoform Symptoms in Parkinson Disease.

IF 1.3 4区 医学 Q4 BEHAVIORAL SCIENCES Cognitive and Behavioral Neurology Pub Date : 2022-12-01 DOI:10.1097/WNN.0000000000000322
David Glovinsky, Ann L Gruber-Baldini, Seth Himelhoch, Karen E Anderson, Lisa M Shulman
{"title":"Somatoform Symptoms in Parkinson Disease.","authors":"David Glovinsky,&nbsp;Ann L Gruber-Baldini,&nbsp;Seth Himelhoch,&nbsp;Karen E Anderson,&nbsp;Lisa M Shulman","doi":"10.1097/WNN.0000000000000322","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Co-occurring somatoform symptoms complicate the diagnosis and treatment of Parkinson disease (PD).</p><p><strong>Objective: </strong>To learn more about the relationship between somatoform symptoms and PD by comparing demographic and clinical features across PD groups differing in somatoform symptom severity.</p><p><strong>Method: </strong>Using standardized Brief Symptom Inventory-18 (BSI-18) scores to measure somatoform symptom severity, we assigned 1093 individuals with PD to one of four subgroups using comparisons to normative means: low (M < -½ SD), average (M ± ½ SD), high (M +½ SD to +1 SD), very high (M > +1 SD). We used demographics and disease severity measures to assess each subgroup.</p><p><strong>Results: </strong>Most of the individuals with PD (56%) had high or very high somatoform symptom levels. Increased somatoform symptom levels were associated with female gender, lower socioeconomic status, greater disease duration, increased PD severity (Total Unified Parkinson's Disease Rating Scale), greater disability (Older Americans Resource and Services Disability subscale), increased BSI-18 Depression and Anxiety subscale scores, lower cognitive function (Mini-Mental State Examination), lower self-efficacy scores (Self-Efficacy to Manage Chronic Disease Scale), lower quality of life scores (SF-12 Health Status Survey), and greater medical comorbidity (Cumulative Illness Rating Scale-Geriatrics) (all comparisons: P < 0.001). We found no significant between-group differences for age, race, or marital status.</p><p><strong>Conclusion: </strong>Somatoform symptom severity in individuals with PD is associated with greater PD severity and disability and is more common in females and in individuals with low socioeconomic status. Greater awareness of somatoform symptoms should help improve PD treatment.</p>","PeriodicalId":50671,"journal":{"name":"Cognitive and Behavioral Neurology","volume":"35 4","pages":"255-262"},"PeriodicalIF":1.3000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cognitive and Behavioral Neurology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/WNN.0000000000000322","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BEHAVIORAL SCIENCES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Co-occurring somatoform symptoms complicate the diagnosis and treatment of Parkinson disease (PD).

Objective: To learn more about the relationship between somatoform symptoms and PD by comparing demographic and clinical features across PD groups differing in somatoform symptom severity.

Method: Using standardized Brief Symptom Inventory-18 (BSI-18) scores to measure somatoform symptom severity, we assigned 1093 individuals with PD to one of four subgroups using comparisons to normative means: low (M < -½ SD), average (M ± ½ SD), high (M +½ SD to +1 SD), very high (M > +1 SD). We used demographics and disease severity measures to assess each subgroup.

Results: Most of the individuals with PD (56%) had high or very high somatoform symptom levels. Increased somatoform symptom levels were associated with female gender, lower socioeconomic status, greater disease duration, increased PD severity (Total Unified Parkinson's Disease Rating Scale), greater disability (Older Americans Resource and Services Disability subscale), increased BSI-18 Depression and Anxiety subscale scores, lower cognitive function (Mini-Mental State Examination), lower self-efficacy scores (Self-Efficacy to Manage Chronic Disease Scale), lower quality of life scores (SF-12 Health Status Survey), and greater medical comorbidity (Cumulative Illness Rating Scale-Geriatrics) (all comparisons: P < 0.001). We found no significant between-group differences for age, race, or marital status.

Conclusion: Somatoform symptom severity in individuals with PD is associated with greater PD severity and disability and is more common in females and in individuals with low socioeconomic status. Greater awareness of somatoform symptoms should help improve PD treatment.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
帕金森病的躯体形式症状。
背景:同时出现的躯体症状使帕金森病(PD)的诊断和治疗复杂化。目的:通过比较不同躯体症状严重程度的PD组的人口统计学和临床特征,进一步了解躯体症状与PD之间的关系。方法:使用标准化的简要症状清单-18(BSI-18)评分来测量躯体形式症状的严重程度,我们将1093名帕金森病患者分为四个亚组之一,并与标准均值进行比较:低(M<-½SD)、平均(M±½SD),高(M+½SD至+1 SD)、非常高(M>+1 SD)。我们使用人口统计学和疾病严重程度测量来评估每个亚组。结果:大多数PD患者(56%)具有较高或极高的躯体形式症状水平。体型症状水平的增加与女性、较低的社会经济地位、较长的疾病持续时间、PD严重程度的增加(综合帕金森病评定量表)、更大的残疾程度(美国老年人资源和服务残疾分量表)、BSI-18抑郁和焦虑分量表得分的增加、认知功能的降低(小型精神状态检查),较低的自我效能感评分(管理慢性病的自我效能量表)、较低的生活质量评分(SF-12健康状况调查)和较大的医疗共病(累积疾病评定量表老年医学)(所有比较:P<0.001)。我们发现年龄、种族或婚姻状况的组间差异无显著性。结论:帕金森病患者的躯体形式症状严重程度与更严重的帕金森病严重程度和残疾有关,在女性和社会经济地位较低的个体中更常见。提高对身体形态症状的认识应有助于改善帕金森病的治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.40
自引率
7.10%
发文量
68
审稿时长
>12 weeks
期刊介绍: Cognitive and Behavioral Neurology (CBN) is a forum for advances in the neurologic understanding and possible treatment of human disorders that affect thinking, learning, memory, communication, and behavior. As an incubator for innovations in these fields, CBN helps transform theory into practice. The journal serves clinical research, patient care, education, and professional advancement. The journal welcomes contributions from neurology, cognitive neuroscience, neuropsychology, neuropsychiatry, and other relevant fields. The editors particularly encourage review articles (including reviews of clinical practice), experimental and observational case reports, instructional articles for interested students and professionals in other fields, and innovative articles that do not fit neatly into any category. Also welcome are therapeutic trials and other experimental and observational studies, brief reports, first-person accounts of neurologic experiences, position papers, hypotheses, opinion papers, commentaries, historical perspectives, and book reviews.
期刊最新文献
Associations Between Intertemporal Food Choice and BMI in Adult Women: An fMRI Study Using a Quasi-realistic Design. Psychotropic Polypharmacy Leading to Reversible Dementia: A Case Report. The Impact of Lexical-semantic Impairment on Spoken Verb Production in Individuals With Mild Cognitive Impairment. Free-listing and Semantic Knowledge: A Tool for Detecting Alzheimer Disease? The Banana Lady and Other Stories of Curious Behavior and Speech.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1